Miroprofen
From Wikipedia, the free encyclopedia
 |
|
| Clinical data | |
|---|---|
| ATC code | none |
| Identifiers | |
|
|
| Synonyms | Antopen; BRN 0888858; NSC 261037; Ro 07-0582; Y 9213; 2-[4-(1,7-diazabicyclo[4.3.0]nona-2,4,6,8-tetraen-8-yl)phenyl]propanoic acid |
| CAS Number | 55843-86-2  |
| PubChem (CID) | 68752 |
| ChemSpider | 61997 |
| UNII | S00I5XG484 |
| ChEBI | CHEBI:76249  |
| Chemical and physical data | |
| Formula | C16H14N2O2 |
| Molar mass | 266.295 g/mol |
| 3D model (Jmol) | Interactive image |
| Chirality | Racemic mixture |
|
|
|
|
| (what is this?) (verify) |
|
Miroprofen (INN) is an analgesic and NSAID, meaning that it has anti-inflammatory, antipyretic and antiplatelet aggregation activity. Chemically it is a carbocyclic acid and a phenylpropionate.[1]
References[edit]
- ^ Mikashima, H.; Goto, K. (Jan 1982). "[Inhibitory effect of 2-(4-(2-imidazo(1,2-a)pyridyl)phenyl) propionic acid (miroprofen) on platelet aggregation and prostaglandin I2 generation (author's transl)].". Yakugaku Zasshi. 102 (1): 99–103. PMID 7045328.
 |
This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |
